Patents by Inventor Michael Heath

Michael Heath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944883
    Abstract: Systems and apparatus for receiving golf balls include an apparatus including: a body having an ingress and an egress for golf balls passing through the body, wherein each of the golf balls includes a radio frequency identification tag; at least one antenna of a radio frequency identification reader, the at least one antenna arranged with respect to the body to receive information from the golf balls for identification of the golf balls; and multiple protrusions located within the body, the multiple protrusions being positioned with respect to each other in a Galton configuration that both (i) impedes the golf balls from passing through the body without being read by the radio frequency identification reader, and (ii) allows the golf balls to pass through the body without jamming therein.
    Type: Grant
    Filed: April 6, 2023
    Date of Patent: April 2, 2024
    Assignee: Topgolf International, Inc.
    Inventors: Brian David Burdette, Gabriel Heath Denk, Justin Dean Pendleton, Michael Ryan Petri
  • Publication number: 20240104407
    Abstract: Various embodiments of the present disclosure provide methods, apparatus, systems, computing devices, computing entities, and/or the like for allocating resources. The method comprises receiving, by a computing device using a resource allocation machine learning framework, historical data comprising one or more causal variables corresponding to one or more actions or inactions with respect to one or more resource-requesting entities and one or more outcomes of one or more actions, identifying, by the computing device, given ones of one or more resource-requesting entity subgroups based at least in part on the one or more causal effect predictions, and performing, by the computing device, one or more prediction-based actions based at least in part on the identification of the given one or more resource-requesting entity subgroups.
    Type: Application
    Filed: September 26, 2022
    Publication date: March 28, 2024
    Inventors: Michael J. McCarthy, Conor J. Waldron, Kieran O'Donoghue, Kevin A. Heath
  • Patent number: 11937027
    Abstract: The present disclosure describes a telecommunications equipment mount. The mount includes a stabilization frame having a bottom and at least three sides, the bottom and sides defining an open interior cavity, at least one mounting member perpendicular to one of the sides of the stabilization frame and extending outwardly from the side of the stabilization frame a distance, and at least one brace member. The at least one brace member includes a first bracket coupled to one side of the stabilization frame and configured to be secured to the at least one mounting member and a second bracket extending outwardly from the same side of the stabilization frame at an angle. A first end of the second bracket is coupled to a lower end of the first bracket and a second opposing end of the second bracket is configured to be secured to the at least one mounting member at a different location than the first bracket.
    Type: Grant
    Filed: September 8, 2022
    Date of Patent: March 19, 2024
    Assignee: CommScope Technologies LLC
    Inventors: Jyoti Ojha, Dale Heath, Michael Carnes, Kevin Ray Paswalk
  • Publication number: 20240069859
    Abstract: A process for receiving, through a virtual assistant application, a first modality input related to a transaction profile. The process may involve identifying utterances from the first modality input. The process may further involve adjust a transaction service schema based on utterances identified from the first modality input and responding, through the virtual assistant application, with a first output derived from the transaction service schema. The process may further involve receiving, through the virtual assistant application, a second modality input related to the transaction profile. The process may then involve identifying utterances from the second modality input. The process may then involve adjusting the transaction service schema based on utterances identified from the second modality input. The process may conclude with responding, through the virtual assistant application, with a second output derived from the transaction service schema.
    Type: Application
    Filed: August 30, 2022
    Publication date: February 29, 2024
    Applicant: Truist Bank
    Inventors: Alex Heath Misiaszek, Michael Anthony Dascola, Christopher Detzi, Gabriel Sheridan
  • Patent number: 11649267
    Abstract: The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.
    Type: Grant
    Filed: July 13, 2021
    Date of Patent: May 16, 2023
    Assignee: THE MITRE CORPORATION
    Inventor: Michael Heath Farris
  • Publication number: 20230002760
    Abstract: CRISPR/Cas-related compositions and methods which provide for efficient gene editing of eukaryotic cells using modified gRNAs.
    Type: Application
    Filed: January 10, 2022
    Publication date: January 5, 2023
    Inventors: Gordon Grant Welstead, Jennifer Leah Gori, Jack Michael Heath, David A. Bumcrot
  • Publication number: 20220380661
    Abstract: A quaternized alkoxylated polyethylene amine can be used in a variety of industries, including the oil and gas servicing industry, as a laundry detergent, the personal care industry, as an industrial cleaner, paint, or coating, and mining operations industry. A treatment fluid comprises: a base fluid; and the surfactant. A method of treating a subterranean formation comprises introducing the treatment fluid into a well, wherein the well penetrates the subterranean formation.
    Type: Application
    Filed: July 28, 2022
    Publication date: December 1, 2022
    Applicant: ARC PRODUCTS, INC.
    Inventors: Michael HEATH, Bobby VITEAUX
  • Patent number: 11460377
    Abstract: Various embodiments directed to a work stand for holding a microscopic collection device for collecting a microscopic sample from a target surface, are provided. The work stand includes a first slit formed on a top surface of the work stand and capable of holding a first microscopic collection device comprising a first holding element and a first collection platform, wherein the first collection platform of the first microscopic collection device is perpendicular to the top surface. A second slit formed on the top surface of the work stand and capable of holding a second microscopic collection device comprising a second collection platform and a second holding element at an angle to the second collection platform perpendicular to the top surface of the work stand.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: October 4, 2022
    Assignee: THE MITRE CORPORATION
    Inventors: Michael Heath Farris, Kevin Robert Gemp, David Masters
  • Publication number: 20220000989
    Abstract: The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.
    Type: Application
    Filed: July 13, 2021
    Publication date: January 6, 2022
    Applicant: The MITRE Corporation
    Inventor: Michael Heath Farris
  • Patent number: 11090370
    Abstract: The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: August 17, 2021
    Assignee: The MITRE Corporation
    Inventor: Michael Heath Farris
  • Publication number: 20210171826
    Abstract: An additive comprising: a polymeric weak acid, wherein the polymeric weak acid is in a free acid form or in a monovalent, divalent, or trivalent salt form of the polymeric weak acid, and wherein the additive converts an invert emulsion having an external phase comprising a hydrocarbon liquid to an emulsion having an external phase comprising water. The additive can be added to the invert emulsion in a dry form or included in a base fluid. The invert emulsion can include polyvalent cations. The base fluid can also include a second additive comprising polyvalent cations.
    Type: Application
    Filed: August 16, 2019
    Publication date: June 10, 2021
    Applicant: ARC PRODUCTS, INC.
    Inventors: Caroline VITEAUX, Mark ALEXANDER, Michael HEATH
  • Patent number: 11027861
    Abstract: Embodiments disclosed herein include needle-free syringe and cap assemblies and filling tub systems. One embodiment of filling tub system includes a filling tub having exterior walls and a floor. The floor is formed into a plurality of sockets configured to receive and support a plurality of cap and syringe body assemblies, with each cap and syringe assembly received in a separate socket. Furthermore, each socket is configured to receive and support a syringe and cap assembly with contact only between one or more surfaces of the socket and selected outer surfaces of the cap. Methods of pre-filling a quantity of needle-free syringes are also disclosed.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: June 8, 2021
    Assignee: PharmaJet Inc.
    Inventors: Michael Heath, Chris Cappello
  • Patent number: 11001880
    Abstract: Techniques are provided for locating and validating single-nucleotide polymorphism (SNP) islands by scanning a reference genome. A system scans a reference genome to locate a high-variance region containing at least a minimum number of known impactful SNP locations in less than a maximum length, wherein the high-variance region is flanked by low-variance regions of at least minimum length and each having fewer than a maximum number of known relevant SNP locations. The system allows for tuning maximum and minimum region lengths, maximum and minimum SNP-location quantities, and rate-of-occurrence thresholds that define relevant and/or impactful SNP locations. Primers are designed for portions of the low-variance regions that are unique within the reference genome, wherein the primers amplify for the high-variance region.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: May 11, 2021
    Assignee: The MITRE Corporation
    Inventors: Michael Heath Farris, Andrew Roger Scott, Pamela Ann Texter
  • Publication number: 20200353058
    Abstract: The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.
    Type: Application
    Filed: May 12, 2020
    Publication date: November 12, 2020
    Applicant: The MITRE Corporation
    Inventor: Michael Heath Farris
  • Publication number: 20200316544
    Abstract: A quaternized alkoxylated polyethylene amine can be used in a variety of industries, including the oil and gas servicing industry, as a laundry detergent, the personal care industry, as an industrial cleaner, paint, or coating, and mining operations industry. A treatment fluid comprises: a base fluid; and the surfactant. A method of treating a subterranean formation comprises introducing the treatment fluid into a well, wherein the well penetrates the subterranean formation.
    Type: Application
    Filed: December 18, 2018
    Publication date: October 8, 2020
    Applicant: ARC PRODUCTS, INC.
    Inventors: Michael HEATH, Bobby VITEAUX
  • Publication number: 20200217757
    Abstract: Various embodiments directed to a work stand for holding a microscopic collection device for collecting a microscopic sample from a target surface, are provided. The work stand includes a first slit formed on a top surface of the work stand and capable of holding a first microscopic collection device comprising a first holding element and a first collection platform, wherein the first collection platform of the first microscopic collection device is perpendicular to the top surface. A second slit formed on the top surface of the work stand and capable of holding a second microscopic collection device comprising a second collection platform and a second holding element at an angle to the second collection platform perpendicular to the top surface of the work stand.
    Type: Application
    Filed: March 17, 2020
    Publication date: July 9, 2020
    Inventors: Michael Heath FARRIS, Kevin Robert GEMP, David MASTERS
  • Patent number: 10688161
    Abstract: The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: June 23, 2020
    Assignee: The MITRE Corporation
    Inventor: Michael Heath Farris
  • Patent number: 10634584
    Abstract: A microscopic collection device, method for collecting a microscopic sample from a target surface, and the work stand for holding the microscopic collection device are provided. The microscopic collection device includes a holding element comprising a handle at one end and a collection platform connected to the holding element at a second end. The collection platform includes a collection surface on which the microscopic sample is deposited when the microscopic collection device comes into contact with the target surface. A tape is inserted through a slit and wrapped around the collection platform. The work stand includes a slit capable of holding the microscopic collection device such that the collection platform is perpendicular to the top surface of the work stand. A microscopic sample, collected using the microscopic collection device, is not only collected from the target surface but is also concentrated onto the collection face of the tape.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: April 28, 2020
    Assignee: ROKU, INC.
    Inventors: Michael Heath Farris, Kevin Robert Gemp, David Masters
  • Publication number: 20180362194
    Abstract: Embodiments disclosed herein include needle-free syringe and cap assemblies and filling tub systems. One embodiment of filling tub system includes a filling tub having exterior walls and a floor. The floor is formed into a plurality of sockets configured to receive and support a plurality of cap and syringe body assemblies, with each cap and syringe assembly received in a separate socket. Furthermore, each socket is configured to receive and support a syringe and cap assembly with contact only between one or more surfaces of the socket and selected outer surfaces of the cap. Methods of pre-filling a quantity of needle-free syringes are also disclosed.
    Type: Application
    Filed: August 22, 2018
    Publication date: December 20, 2018
    Inventors: Michael Heath, Chris Cappello
  • Publication number: 20180353576
    Abstract: The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.
    Type: Application
    Filed: May 4, 2018
    Publication date: December 13, 2018
    Applicant: The MITRE Corporation
    Inventor: Michael Heath FARRIS